Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
This study has been completed.
Sponsor:
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
Teva Pharmaceuticals USA
ClinicalTrials.gov Identifier:
NCT01686152
First received: September 12, 2012
Last updated: December 5, 2013
Last verified: December 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2013 |
| Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |